These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26352211)

  • 41. Toolbox for Antibiotics Discovery from Microorganisms.
    Fisch KM; Schäberle TF
    Arch Pharm (Weinheim); 2016 Sep; 349(9):683-91. PubMed ID: 27311607
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genomic mining--a concept for the discovery of new bioactive natural products.
    Gross H
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):207-19. PubMed ID: 19333866
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hybrid isoprenoid secondary metabolite production in terrestrial and marine actinomycetes.
    Gallagher KA; Fenical W; Jensen PR
    Curr Opin Biotechnol; 2010 Dec; 21(6):794-800. PubMed ID: 20951024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Macrolactam analogues of macrolide natural products.
    Hügel HM; Smith AT; Rizzacasa MA
    Org Biomol Chem; 2016 Dec; 14(48):11301-11316. PubMed ID: 27812587
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New approaches to antimicrobial discovery.
    Lewis K
    Biochem Pharmacol; 2017 Jun; 134():87-98. PubMed ID: 27823963
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioprospecting microbial natural product libraries from the marine environment for drug discovery.
    Liu X; Ashforth E; Ren B; Song F; Dai H; Liu M; Wang J; Xie Q; Zhang L
    J Antibiot (Tokyo); 2010 Aug; 63(8):415-22. PubMed ID: 20606699
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Applications and Restrictions of Integrated Genomic and Metabolomic Screening: An Accelerator for Drug Discovery from Actinomycetes?
    Krause J
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34576921
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An Engineered Allele of afsQ1 Facilitates the Discovery and Investigation of Cryptic Natural Products.
    Daniel-Ivad M; Hameed N; Tan S; Dhanjal R; Socko D; Pak P; Gverzdys T; Elliot MA; Nodwell JR
    ACS Chem Biol; 2017 Mar; 12(3):628-634. PubMed ID: 28075554
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutational biosynthesis--a tool for the generation of structural diversity in the biosynthesis of antibiotics.
    Weist S; Süssmuth RD
    Appl Microbiol Biotechnol; 2005 Aug; 68(2):141-50. PubMed ID: 15702315
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Culturable rare Actinomycetes: diversity, isolation and marine natural product discovery.
    Subramani R; Aalbersberg W
    Appl Microbiol Biotechnol; 2013 Nov; 97(21):9291-321. PubMed ID: 24057404
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Harnessing Rare Actinomycete Interactions and Intrinsic Antimicrobial Resistance Enables Discovery of an Unusual Metabolic Inhibitor.
    McClung DJ; Du Y; Antonich DJ; Bonet B; Zhang W; Traxler MF
    mBio; 2022 Jun; 13(3):e0039322. PubMed ID: 35608300
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Triggers and cues that activate antibiotic production by actinomycetes.
    Zhu H; Sandiford SK; van Wezel GP
    J Ind Microbiol Biotechnol; 2014 Feb; 41(2):371-86. PubMed ID: 23907251
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Occurrence, distribution, dereplication and efficient discovery of thiazolyl peptides by sensitive-resistant pair screening.
    Singh SB; Zhang C; Zink DL; Herath K; Ondeyka J; Masurekar P; Jayasuriya H; Goetz MA; Tormo JR; Vicente F; Martín J; González I; Genilloud O
    J Antibiot (Tokyo); 2013 Oct; 66(10):599-607. PubMed ID: 23801187
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Marine actinobacteria: an important source of bioactive natural products.
    Manivasagan P; Kang KH; Sivakumar K; Li-Chan EC; Oh HM; Kim SK
    Environ Toxicol Pharmacol; 2014 Jul; 38(1):172-88. PubMed ID: 24959957
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Natural and engineered biosynthesis of nucleoside antibiotics in Actinomycetes.
    Chen W; Qi J; Wu P; Wan D; Liu J; Feng X; Deng Z
    J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):401-17. PubMed ID: 26153500
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of a Cryptic Antifungal Compound from Streptomyces albus J1074 Using High-Throughput Elicitor Screens.
    Xu F; Nazari B; Moon K; Bushin LB; Seyedsayamdost MR
    J Am Chem Soc; 2017 Jul; 139(27):9203-9212. PubMed ID: 28590725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endophytic Actinobacteria from the Brazilian Medicinal Plant Lychnophora ericoides Mart. and the Biological Potential of Their Secondary Metabolites.
    Conti R; Chagas FO; Caraballo-Rodriguez AM; Melo WG; do Nascimento AM; Cavalcanti BC; de Moraes MO; Pessoa C; Costa-Lotufo LV; Krogh R; Andricopulo AD; Lopes NP; Pupo MT
    Chem Biodivers; 2016 Jun; 13(6):727-36. PubMed ID: 27128202
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biosynthesis of sulfonamide and sulfamate antibiotics in actinomycete.
    Awakawa T; Barra L; Abe I
    J Ind Microbiol Biotechnol; 2021 Jun; 48(3-4):. PubMed ID: 33928358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure and biosynthetic assembly of gulmirecins, macrolide antibiotics from the predatory bacterium Pyxidicoccus fallax.
    Schieferdecker S; König S; Weigel C; Dahse HM; Werz O; Nett M
    Chemistry; 2014 Nov; 20(48):15933-40. PubMed ID: 25287056
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The biosynthesis of glycopeptide antibiotics--a model for complex, non-ribosomally synthesized, peptidic secondary metabolites.
    Süssmuth RD; Wohlleben W
    Appl Microbiol Biotechnol; 2004 Jan; 63(4):344-50. PubMed ID: 14564489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.